Long-term safety and effectiveness of lopinavir/ritonavir in antiretroviral-experienced HIV-1-infected children
ContributorsRudin, Christoph; Wolbers, Marcel; Nadal, David; Rickenbach, Martin; Bucher, Heiner C; the Pediatric Infectious Disease Group of Switzerland (PIGS); the Swiss Mother and Child HIV Cohort Study (MoCHiV)
Published inArchives of disease in childhood, vol. 95, no. 6, p. 478-481
Publication date2010
Abstract
Keywords
- Adolescent
- CD4 Lymphocyte Count
- Child
- Child, Preschool
- Drug Therapy, Combination
- Female
- Follow-Up Studies
- HIV Infections/drug therapy/immunology/virology
- HIV Protease Inhibitors/adverse effects/therapeutic use
- HIV-1/isolation & purification
- Humans
- Lopinavir
- Male
- Prospective Studies
- Pyrimidinones/adverse effects/therapeutic use
- Ritonavir/adverse effects/therapeutic use
- Treatment Outcome
- Viral Load
Citation (ISO format)
RUDIN, Christoph et al. Long-term safety and effectiveness of lopinavir/ritonavir in antiretroviral-experienced HIV-1-infected children. In: Archives of disease in childhood, 2010, vol. 95, n° 6, p. 478–481. doi: 10.1136/adc.2009.169375
Main files (1)
Article (Published version)
Identifiers
- PID : unige:41545
- DOI : 10.1136/adc.2009.169375
- PMID : 20501542
Journal ISSN0003-9888
